A Q4 2023 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q4 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.7B-8.7% YoY

Gross Profit

$915M54.2% margin

Operating Income

$408M24.2% margin

Net Income

$475M28.1% margin

EPS (Diluted)

$1.62

QoQ Revenue Growth

+1.0%

Cash Flow

Operating Cash Flow

$516M

Free Cash Flow

$432M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$10.8B

Total Liabilities

$4.9B

Stockholders' Equity

$5.8B

Cash & Equivalents

$1.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.8B	-8.7%
Gross Profit	$915M	$1.0B	-9.6%
Operating Income	$408M	$471M	-13.4%
Net Income	$475M	$368M	+29.1%

Revenue Segments

Life Sciences and Applied Markets

$928M55%

Agilent CrossLab

$404M24%

Diagnostics and Genomics

$356M21%

Geographic Segments

Americas

$702M42%

Asia Pacific

$553M33%

Europe

$433M26%